The SLCan Board of Directors is pleased to announce that the next Chapter to be launched will be the Vancouver Chapter, approved in June 2023. The Chapter Board will be led by Founding President Kevin Shea (Introba), Vice President Kevin Shelast (Aqua Air Systems Ltd.), Treasurer Corey Hiebert (Alliance Scientific Inc.) and Secretary Barbara Nobmann (Abdera Therapeutics Inc.). Membership in the Chapter is included in SLCan's annual membership fees. Visit https://slcan.ca/
Stay tuned to SLCan's eZINEs and social media accounts for updates on Chapter events.
Creating a Science Hub in Vancouver, Life Science Spaces – Now and Future
This year, British Columbia launched its Biomanufacturing strategy, outlining key priorities to nurture innovation and bolster the province’s business ecosystem. This strategic approach proactively seeks to achieve several objectives, including the generation of high-income positions within the biomanufacturing sector, the retention of companies and intellectual property within British Columbia, the establishment of connections with global life sciences markets, the enhancement of access to ground-breaking medical treatments, the attraction of skilled talent, support for a sustainable economy, and the reinforcement of pandemic response capabilities.
At the core of this strategy lies the imperative need to enhance the Life Science infrastructure supply, which involves creating a diverse array of laboratory spaces, encompassing research offices, dry labs, wet labs, and specialized research facilities tailored to meet unique requirements. The limited availability of such laboratory spaces in the Lower Mainland currently stands as a significant obstacle, hampering research outcomes and the growth prospects of local startups and businesses.
In its inaugural event, the Vancouver chapter of SLCan is bringing together an esteemed panel of experts, comprising tenants of recently established research facilities, life science developers, and real estate transaction experts, to conduct an in-depth exploration of the challenges associated with laboratory space development.
Please remember to secure your spot today to actively participate in the conversation and make the most of the networking opportunities available.
Speakers for the Panel Discussion
Adam Mitchell, Vice President, Asset Management and Development, Low Tide Properties
Jason Crawford, EVP, Drug Discovery, Gandeeva Therapeutics
Blair Quinn, Co-founder, HTFG and Vice Chairman, CBRE
Mark Nykolaichuk, Facilities / Operations Manager, Acuitas Therapeutics, Inc.
Moderator: Kevin Shea, Principal, Science and Technology, Introba
Hilton Downtown Vancouver
433 Robson Street Vancouver, BC V6B 6L9
4:30 pm to 5:30 pm – Appetizers, Drinks & Networking
5:30 pm to 6:15 pm – Panel Discussion
6:15 pm to 8:00 pm – Networking
Cost (no payment at the door)
SLCan Member: $ 45 CAD + Taxes
Non-Member: $ 65 CAD + Taxes